Vyvanse / Lisdexamfetamine → 🇺🇸 United States

Full details

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply. Quantity guidance for United States: Up to 90-day personal supply; DEA Schedule II — must be in original pharmacy packaging. Documentation: Original prescription from licensed US physician; Medication in original pharmacy-labelled packaging; Doctor's letter stating medical necessity (recommended for international travel). Enforcement in United States carries fines from USD 300 to USD 10,000 under 19 USC § 1497 (failure to declare); 19 USC § 1592 (fraudulent entry) (ordinary personal cases are handled as civil infringements). Restricted status means compliant carriage is achievable with the right paperwork and quantities; the practical risks are seizure, duty, and delay rather than criminal liability for a good-faith traveller. Arrival checks are carried out by U.S. Customs and Border Protection (CBP); when in doubt use the declare (red) channel — declared goods at worst attract duty or surrender, while undeclared goods attract penalties. Leaving United States with vyvanse / lisdexamfetamine is a separate question: restricted — Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from United States requires prescription documentation and stays within personal-use limits.

Leaving United States with vyvanse / lisdexamfetamine

Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the 21 USC § 956 (personal-use exception); DEA Diversion regulations framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from United States; above these limits a DEA Form 236 (for Schedule II above personal-use limit) is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.

OFFICIAL SOURCES · VERIFIED 2026-08-22